HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regulation of human separase by securin binding and autocleavage.

AbstractBACKGROUND:
Sister chromatid separation is initiated by separase, a protease that cleaves cohesin and thereby dissolves sister chromatid cohesion. Separase is activated by the degradation of its inhibitor securin and by the removal of inhibitory phosphates. In human cells, separase activation also coincides with the cleavage of separase, but it is not known if this reaction activates separase, which protease cleaves separase, and how separase cleavage is regulated.
RESULTS:
Inhibition of separase expression in human cells by RNA interference causes the formation of polyploid cells with large lobed nuclei. In mitosis, many of these cells contain abnormal chromosome plates with unseparated sister chromatids. Inhibitor binding experiments in vitro reveal that securin prevents the access of substrate analogs to the active site of separase. Upon securin degradation, the active site of full-length separase becomes accessible, allowing rapid autocatalytic cleavage of separase at one of three sites. The resulting N- and C-terminal fragments remain associated and can be reinhibited by securin. A noncleavable separase mutant retains its ability to cleave cohesin in vitro.
CONCLUSIONS:
Our results suggest that separase is required for sister chromatid separation during mitosis in human cells. Our data further indicate that securin inhibits separase by blocking the access of substrates to the active site of separase. Securin proteolysis allows autocatalytic processing of separase into a cleaved form, but separase cleavage is not essential for separase activation.
AuthorsIrene Waizenegger, Juan F Giménez-Abián, Dominik Wernic, Jan-Michael Peters
JournalCurrent biology : CB (Curr Biol) Vol. 12 Issue 16 Pg. 1368-78 (Aug 20 2002) ISSN: 0960-9822 [Print] England
PMID12194817 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cell Cycle Proteins
  • Chromosomal Proteins, Non-Histone
  • Enzyme Inhibitors
  • Fungal Proteins
  • MCD1 protein, S cerevisiae
  • Neoplasm Proteins
  • Nuclear Proteins
  • Peptides
  • Phosphoproteins
  • Saccharomyces cerevisiae Proteins
  • Securin
  • Trans-Activators
  • pituitary tumor-transforming protein 1, human
  • Endopeptidases
  • ESP1 protein, S cerevisiae
  • ESPL1 protein, human
  • Separase
Topics
  • Amino Acid Sequence
  • Animals
  • Cell Cycle Proteins (antagonists & inhibitors, metabolism)
  • Cell Nucleus (metabolism)
  • Chromosomal Proteins, Non-Histone
  • Chromosomes (metabolism)
  • Endopeptidases
  • Enzyme Activation
  • Enzyme Inhibitors (metabolism)
  • Fungal Proteins (genetics, metabolism)
  • HeLa Cells
  • Humans
  • Mitosis (genetics)
  • Models, Biological
  • Molecular Structure
  • Neoplasm Proteins (metabolism)
  • Nuclear Proteins
  • Peptides (metabolism)
  • Phosphoproteins
  • Polyploidy
  • Protein Binding
  • RNA Interference
  • Saccharomyces cerevisiae Proteins
  • Securin
  • Separase
  • Sequence Alignment
  • Trans-Activators (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: